This study deals with the effect of 5-hydroxytryptamine (5-HT; serotonin) on glucose transport in isolated rat cardiac myocytes. In these cells, 5-HT (10-300,M), as well as tryptamine, 5-methoxytryptamine and dopamine, elicited a 3-5-fold increase in glucose transport, as compared with control. This effect was maximal after 90 min, and was concomitant with a 1.8-and 1.5-fold increase in the amounts of glucose transporters GLUTI and GLUT4 at the cell surface of the cardiomyocytes, as determined by using the photoaffinity label 3H-2-N-[4-(1-azi-2,2,2-trifluoroethyl)benzoyl]-1,3-bis-(D-mannos-4-yl)propyl-2-amine (3H-ATB-BMPA). In contrast, 3-3000 1M of the selective 5-HT receptor agonists 5-carboxyamido-tryptamine, ac-methyl-serotonin, 2-methyl-serotonin or renzapride failed to stimulate glucose transport. The effect of 5-HT was not affected by (i) the 5-HT 
INTRODUCTION
Many investigations performed in vivo suggest that 5-hydroxytryptamine (5-HT; serotonin) may play a role in the regulation of blood glucose. Thus, injection of tryptophan, 5-hydroxytryptophan (both precursors of 5-HT), or 5-HT itself, has been reported to result in hypoglycaemia in rodents [1] [2] [3] [4] [5] [6] . Moreover, 5-HT receptor antagonists were shown to inhibit this hypoglycaemic effect [3, 4] , or themselves to have hyperglycaemic properties [7] . On the other hand, hyperglycaemia has also been observed upon administration of 5-HT [1] or 5-HT receptor agonists [8] [9] [10] [11] . The picture is further complicated by the fact that some of these effects seem to be related to changes in the plasma level of insulin [4, 6, 8, 9, 11] , but some are not [1, 3, 9] . In addition, central-nervous-system events appear to be involved in some instances [2, [8] [9] [10] , whereas in other cases evidence for peripheral mechanisms was presented [1, 3, 5, 11] .
Taken together, these investigations indicate that the influence of serotonergic mechanisms on glucose metabolism depends on the complex interplay of neuronal and hormonal factors operating in vivo. To our knowledge, no approach in vitro has been attempted to identify the possible site(s) of action of 5-HT. In particular, the question of which metabolic processes are directly involved in the reported effects on blood glucose is unsolved. The pattern of changes in liver metabolites observed by Smith and Pogson upon tryptophan administration seem to exclude an involvement of hepatic gluconeogenesis [3] .
The purpose of the present work was to examine the possibility of a direct effect of 5-HT on muscle glucose utilization, since glucose disposal by muscle tissue is a determinant factor in the control of glycaemia. To this end, we used isolated cardiac myocytes, which have proved to be a useful model to investigate the control of glucose metabolism at the cellular level [12] [13] [14] . In particular, we focused on the action of 5-HT on the uptake of glucose across the plasma membrane, because glucose transport is known to be a major rate-limiting and highly regulated step of hexose utilization in heart and skeletal muscle [15] [16] [17] .
EXPERIMENTAL Chemicals
All chemicals were of highest purity grade available. H202, the detergent Thesit, as well as all chemicals for media used for Abbreviations used: 5-HT, 5-hydroxytryptamine (serotonin); 5-HIM, 5-hydroxy-1 H-indol-3-ylacetic acid; 3H-ATB-BMPA, 3H-2-N-[4-(1-azi-2,2,2-trifluoroethyl)benzoyl]-1,3-bis-(D-mannos-4-yloxy)propyl-2-amine; cAMP, cyclic AMP; cGMP, cyclic GMP; MAO, monamine oxidase; 6,7-ADTN, (±)-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene; PMA, 4f-phorbol 12f-myristate 13a-acetate.
t To whom corresporndence should be addressed.
cell isolation and glucose transport assays were from Merck (Darmstadt, Germany); 4fl-phorbol 12,-myristate 13a-acetate (PMA), prazosin, propranolol, yohimbine, ketanserin, (-)-isoprenaline, dibutyryl cyclic AMP, dopamine, tryptamine, 5-HT, clorgyline, tranylcypromine, antipain, aprotinin, pepstatin and leupeptin were obtained from Sigma (Deisenhofen, Germany); sodium nitroprusside was from Fluka Chemie AG (Buchs, Switzerland); BSA (fraction V, fatty-acid-free), glutathione (oxidized) and catalase (from bovine liver) were from Boehringer (Mann4eim, Germany); methysergide, cyproheptadine, haloperidol, R(+)-SCH-23390, MDL 72222 (3-tropanyl-3,5-dichlorobenzoate), 5-carboxyamido-tryptamine, a-methylserotonin, 2-methyl-serotonin, (±)-amino-6,7-dihydroxy-1,2,3,4- Isolation of cardlomyocytes and determination of 2-deoxy-Dglucose uptake
Cardiomyocytes from adult Sprague-Dawley rats (180-220 g, fed ad libitum) were obtained as previously described [18] . The uptake of 2-deoxy-D-[3H]glucose was assayed in medium containing 6 mM KCl, 1 mM Na2HPO4, 0.2 mM NaH2PO4, 1.4 mM MgSO4, 128 mM NaCl, 10 mM Hepes, 1 mM CaCl2 and 2% BSA (fatty-acid-free), pH 7.4, 37 'C, equilibrated with oxygen, as described [18] . In brief, 1 ml of cell suspension (corresponding to approx. 1.5 mg of cell protein) was incubated with 0.5 ml of medium (control) or with an appropriate dilution of one or several agents to be assayed, in a shaking water bath at 37 'C for the times indicated. Figure 7b ) was compared with that of an internal standard (50 ,uM final concentration) added to extracts from control samples (Figure 7c ). The concentrations are expressed in mmol/litre of cellular water space (see also below, under 'Calculations and statistics').
Photoaffinity labelling of glucose transporters GLUT1 and GLUT4 at the surface of cardiomyocytes The labelling of glucose transporters present at the surface of cardiomyocytes was adapted from a method previously described [23, 24] . Cardiomyocytes (approx. (6 mm each), the pieces were dissolved in 30 % H202 containing 2 % NH3, and the radioactivity was measured in a liquid-scintillation counter (Wallac 1409). To quantify the amount of labelled glucose transporters in each sample, the background of the gel slices was subtracted from the (only) peak appearing in the lanes; this peak has an apparent molecular mass of 45 kDa (in anti-GLUTl precipitates) or 50 kDa (in anti-GLUT4 precipitates), corresponding to the known molecular masses of these two proteins.
In preliminary experiments, an irradiation time of 3 min had been found to induce -80% photolysis without affecting the viability of cardiomyocytes. The amount of 75 ,1 of each antiserum was chosen because it caused a maximal precipitation of GLUT1 or GLUT4. Moreover, further control experiments showed that no detectable amount of glucose transporters could be recovered from a second immunoprecipitation with the same antiserum. Finally, the radioactive peak detected on gel electrophoresis was confirmed to represent labelled glucose transporters, since labelling was abolished by the specific glucose-transport inhibitor cytochalasin B (20 #M, added to insulin-stimulated cells before irradiation).
Calculations and statistics
Cell protein was measured by the biuret method. For the determination of cellular concentrations (cAMP and cGMP, see above; 5-HIAA, see Figure 8 ), the water distribution space of cardiomyocytes was calculated by using a previously determined factor of 2.07 ,ul/mg of protein [18] . For the calculation of the EC50 from the data shown in Figure 2 , a logit-log transformation of the original values was performed with a computer program (Prism) from GraphPad Software (San Diego, CA, U.S.A.). A paired Student's t test was used for statistical comparison of data sets shown in Tables 1, 2 level about 5 times that measured in control cells, a maximal stimulation being reached after approx. 90 min (Figure 1 ). The concentration-dependence of this effect is illustrated in Figure 2: the EC50 of glucose transport stimulation by 5-HT is 35 ,uM, as calculated from linearized values corresponding to the data shown.
To investigate which receptor may mediate the response of the glucose transport system to 5-HT, selective agonists to the major 5-HT receptor types were tested. As shown in Figure 3 , all these agents, namely 5-carboxyamido-tryptamine (5-HT,-specific [25, 26] ), a-methyl-serotonin (5-HT2-specific [27, 28] ), 2-methylserotonin (5-HT3-specific [27] [28] [29] ) or renzapride ( = BRL 24924; 5-HT4-specific [30, 31] time-dependence of these effects was similar to that found for 5-HT (Figure 1 ). In addition, glucose transport stimulation by 5- (Figure 4) . Moreover, antagonists to other types of monoamine receptors also failed to alter the extent or the concentrationdependence of the glucose transport increase induced by 5 5-Hydroxytryptamine stimulates glucose transport in cardiomyocytes Table 1 Influence of pertussis toxin, cholera toxin, isoprenaline and Glucose transport stimulation by 5-HT and intracellular signalling
The next approach used to define the pathway by which 5-HT acts on the uptake of glucose in cardiomyocytes was to examine the possible involvement of G-proteins and of the secondmessenger systems that have been reported to mediate other effects of 5-HT. As shown in Table 1 , pre-treatment of myocytes with cholera toxin (1 #sg/ml) for 120 min depressed the effect of 5-HT by 33 %, whereas pertussis toxin (1 jug/ml) had no significant influence. However, cholera toxin is known to raise the cAMP concentration in this and other cell types [19] . Since the 5-HT-dependent increase in glucose transport was inhibited to a similar extent by the ,J-adrenergic agonist isoprenaline (1 ,uM) and by the membrane-permeant cAMP analogue dibutyryl cAMP (0.1 mM) (Table 1) , the toxin's effect is likely to involve an elevated concentration of the cyclic nucleotide, rather than the inhibition of a cholera-toxin-sensitive G-protein activatable by 5-HT. It is well known that 5-HT receptors of the 5-HT1 subtypes are negatively coupled to the adenylate cyclase [28, 32] . Since the effect of 5-HT on glucose transport was antagonized by interventions elevating the cAMP level in cardiomyocytes (see Table  1 ), it is conceivable that 5-HT exerts its stimulating effect by lowering the cAMP level in these cells. However, when cardiomyocytes were incubated in the presence of 5-HT (100 uM) for 0.5-90 min, no significant change in their cAMP content was found (Figure 6a ). Note that isoprenaline led, as expected, to a rapid and large increase in cAMP in these cells (Figure 6a) . The lack of effect of 5-HT on the cAMP content also indicates that 5-HT4 receptors are not likely to be involved in the observed glucose-transport stimulation, since these receptors are positively linked to the adenylate cyclase in heart [36, 38] and other tissues [28, 32] .
It is well established that 5-HT2 receptors are coupled to the phosphatidylinositol cascade, and thus trigger the release of inositol trisphosphate and diacylglycerol [28] . We have previously reported that, in cardiomyocytes, the diacylglycerol analogue and protein kinase C activator PMA increases glucose transport about 2-fold [13] . However, when cardiomyocytes were exposed for 90 min to a combined treatment with PMA (0.8 1tM) and 5-HT (300 saM), the [39, 41] . We have therefore examined the possibility that the rise in glucose transport induced by 5-HT in cardiomyocytes may be preceded or correlated with a release of cGMP. As illustrated in Figure 6 (b), 5-HT (100 ,uM) failed to influence the cGMP concentration over a period of 30 min, i.e. in a time span in which glucose-transport stimulation becomes apparent (Figure 1 ). It is noteworthy that nitroprusside (100,u1M), which caused a marked rise in cGMP in cardiomyocytes (Figure 6b ), had no effect on glucose transport when added to these cells for either 15 or 45 min (results not shown).
Involvement of 5-HT metabolism In glucose-transport stimulation
In view of (i) the slow onset of glucose-uptake activation by 5-HT (Figure 1 ), (ii) the relatively high 5-HT concentrations required (Figure 2) , and, (iii) the fact that no 'classical' 5-HT receptor type, nor an adrenergic or dopaminergic receptor, appears to be involved (see the previous section and Figures 3-5 and Figure 6a) , we considered the hypothesis that the observed effect of 5-HT may be elicited by some product of 5-HT metabolism in cardiomyocytes. Since 5-HT is known to be degraded by monoamine oxidases (MAO) in various organs, including the heart [42, 43] , we assessed the influence of potent MAO inhibitors on the action of 5-HT on glucose transport. As illustrated in Table 2 , preincubation ofmyocytes with the MAO-A-selective inhibitor clorgyline (1 ,uM), as well as the nonselective (MAO-A and MAO-B) inhibitor tranylcypromine (1 1sM), completely prevented the stimulation of glucose uptake by 5-HT ( Table 2 ), indicating that a MAO-dependent step may indeed be essential for the stimulating process. In contrast, the MAO-B-specific inhibitor (-)-deprenyl (1 ,M) was ineffective ( Cardiomyocytes were exposed to 5-HT (300 4aM) for the times indicated before the rate of 2-deoxy-o-glucose transport (El) or the cellular concentration of 5-HIAA (@) was determined as described in the Experimental section. The glucose-transport data are the same as those shown in Figure 1 . The 5-HIAA cellular-concentration data are means of two independent experiments (each experiment was done in duplicate). Table 3 Influence of 5-HT and Insulin on the amount of glucose transporters GLUTI and GLUT4 at the surface of cardlomyocytes Cardiomyocytes were incubated for 90 min at 37 OC in the absence (control) or in the presence of 5-HT (300 ,uM) or insulin (10 nM, for the last 30 min of the incubation) before they were subjected to photoaffinity labelling with 3H-ATB-BMPA, and the amount of cell-surface glucose transporters was quantified, as described in the Experimental section. Data shown represent means + S.E.M. of 5-12 independent experiments, expressed as values normalized to control. The statistical significance of the differences from control was assessed with a paired Student's t test; *P < 0.05; **P < 0.01; ***P < 0.001 versus control.
Relative amount of glucose transporters at the cell surface (compared with 1.00 in control cells) GLUT1 GLUT4 resulting H202 formation eventually leads to the stimulation of glucose transport in these cells. reinforce, i.e. to shift their cellular glutathione system towards a reduced state, and thus to improve their anti-oxidative capacity [44] ) also diminishes the impact of 5-HT, as well as that of exogenously added H202 on glucose transport (Table 2 ) (a concentration of 1 mM glutathione was chosen because it is saturating with respect to the cellular glutathione reduction in these cells [44] ). It should be noted that none of these pretreatments (with MAO inhibitors, catalase or glutathione) affected the basal or the insulin-stimulated rate of glucose transport (Table 2) . Thus, these inhibitors seem to be devoid of general unspecific or even toxic effect at the concentrations used. Semicarbazide (1 mM), an inhibitor of the so-called semicarbazide-sensitive amine oxidase, which is distinct from MAO [43] , did not alter the glucose-transport response to 5-HT (results not shown).
Finally, we examined the possible appearance of known (MAO-derived) products of 5-HT metabolism, namely 5-HIAA and 5-hydroxytryptophol [32] , in extracts from cardiomyocytes previously treated with 5-HT. Analysis of these extracts by reversed-phase HPLC revealed two large peaks that were present in samples from cells treated with 5-HT (300 uM) (Figure 7b , peaks 1 and 2), but not in control samples (Figure 7a ). Parallel HPLC runs with standards (without cell extracts) showed that peaks 1 and 2 exactly correspond to the elution times of 5-HT and 5-HIAA respectively (results not shown). In contrast, no peak corresponding to 5-hydroxytryptophol was detected in samples from 5-HT-treated cells (under the elution conditions used, 5-hydroxytryptophol would appear at the time indicated by the arrow in Figure 7b ). Addition of a 5-HIAA standard to extracts from control cells resulted in the appearance of peak 2 (Figure 7c) . Moreover, when cardiomyocytes were exposed to 5-HT in the presence of tranylcypromine (20 ,uM) , peak 2 disappeared (Figure 7d) .
The intracellular 5-HIAA concentration was calculated from the magnitude of peak 2 (by using internal standards, as in Figure 7c ) and plotted as a function of the duration of cardiomyocyte treatment with 5-HT. As shown in Figure 8 , 5-HIAA accumulates in these cells in a time-dependent manner, and this accumulation approximately parallels the observed increase in glucose transport. Taken together, these findings suggest that 5-HT is taken up and metabolized to 5-HIAA by cardiomyocytes, and that the Effect of 5-HT on glucose-transporter distribution In a last set of experiments, we have addressed the question whether the stimulation of glucose transport by 5-HT may be explained by recruitment ofglucose transporters from an internal storage site to the plasma membrane, as is known to be the case with insulin [45, 46] . For this purpose, we used the specific photoaffinity label 3H-ATB-BMPA. This non-permeant compound allows selective tagging, and thus quantification of the amount, ofglucose transporters present at the cell surface [23, 24] . As shown in Table 3 , exposure of cardiac myocytes to 5-HT (300 gM) for 90 min led to a 1.54-fold increase in the content of GLUT4 (the 'insulin-sensitive', i.e. insulin-recruitable, glucose transporter of muscle and fat tissues). In addition, 5-HT recruits the other transporter isoform, GLUT1, to the cell surface by a factor of 1.79 (Table 3) . By comparison, a saturating concentration of insulin (the most potent stimulus of glucose transport in these cells) caused a 6.05-fold increase in GLUT4 and a 2.94-fold increase in GLUT1. In the same experiments, 5-HT and insulin enhanced the rate of glucose transport by 3.1-and 12.9-fold respectively. Thus the translocation of glucose transporters to the plasma membrane appears to be, at least partially, responsible for the observed changes in glucose transport.
DISCUSSION
5-HT has been suggested to be involved in the control of glycaemia and glucose metabolism [1, [3] [4] [5] [6] [7] [8] [9] [10] [11] . The aim of the present study was to examine the effect in vitro of 5-HT on glucose utilization in a peripheral tissue, namely cardiac muscle cells. In particular, glucose transport was considered because this process limits the overall utilization of glucose in muscle tissue and is known to be regulated by many hormonal and metabolic factors (such as insulin, contractile activity, hypoxia etc.).
In isolated cardiomyocytes, 5-HT caused a concentration-and time-dependent 4-5-fold enhancement in the rate of glucose transport (Figures 1 and 2 ). This effect can be partially explained, like that of insulin, by an increase in the amount of glucose transporters (GLUTI, GLUT4) in the plasma membrane of these cells (Table 3) . However, several findings indicate that the I stimulation of glucose transport by 5-HT does not occur via the same pathway or signal as the effect of insulin. Thus the effect of 5-HT has a slow onset (Figure 1 ), whereas that of insulin is maximal after a few minutes [47] . Moreover, the insulin-dependent stimulation of glucose transport is not affected by agents that largely diminish or even suppress the action of 5-HT, such as cAMP-elevating substances ( [13] , and Table 1) , inhibitors of MAOs, catalase or glutathione (Table 2) .
Attempts to define the receptor type by which 5-HT impinges on the glucose-transport system of cardiac myocytes remained unsuccessful. Thus the action of 5-HT was not mimicked by selective agonists to known 5-HT receptors such as 5-carboxyamido-tryptamine (5-HT1 [25, 26] ), a-methyl-serotonin (5-HT2 [27, 28] Our experiments examining signal-transduction pathways of known 5-HT receptors also indicate that no 'classical' 5-HT receptor mediates the effect of 5-HT on glucose transport. The finding that 5-HT was devoid of effect on the cAMP level in cardiomyocytes (Figure 6a ) seems to exclude the involvement of 5-HT1 receptors (that are negatively coupled to the adenylate cyclase [28] ), as well as 5-HT4 receptors (that are positively coupled to the adenylate cyclase [30] ). It should be noted that 5-HT4 receptors were found in human [38] and pig heart [36] preparations, but we are not aware of reports on 5-HT4 (or 5-HT1) receptors in the rat heart. Furthermore, the additivity of the stimulation by 5-HT, on the one hand, with that of the protein kinase C activator PMA, on the other hand, suggests that this kinase is not responsible for the effect of 5-HT on glucose transport; this indirectly suggests that no 5-HT2 receptors, which are known to cause the breakdown of phosphatidylinositol and the release of the protein kinase C activator diacylglycerol [28] , are mobilized in these cells under the experimental conditions used. Finally, this study rules out an involvement of cGMP (Figure 6b ), which was shown to mediate a fast 5-HT3-dependent response to 5-HT [39] [40] [41] and a slow response unrelated to classical 5-HT receptors [39, 41] in neuronal cell lines.
Although the involvement of the more recently discovered 5-HT5, 5-HT6 and 5-HT7 receptors was not assessed in the present study, the results of these pharmacological approaches, along with the slow onset of glucose transport stimulation by 5-HT and the requirement for relatively high concentrations of the monoamine, led us to consider the possibility that no receptor-derived signal, but rather a product of 5-HT metabolism, may induce the effect observed in cardiomyocytes. We indeed found experimental evidence supporting this hypothesis. First, the effect of 5-HT was completely suppressed by inhibitors of monoamine oxidases (Table 2) . Second, the increase in glucose transport correlates with the appearance and accumulation in cardiomyocytes of 5-HIAA (Figures 7 and 8) , a metabolite derived from the MAOdependent degradation of 5-HT [32] . Third, H202, a known product of monoamine oxidation [43] , is a potent stimulator of glucose transport in these cells ( [13] ; Table 2 ), and the effect of 5-HT is inhibited by interventions promoting the removal of cellular H202 and/or inhibiting the effect of exogenous H202 (addition of catalase or of glutathione; [43] . In addition, MAO-A has been shown to be the predominant form of MAO in the adult rat heart [48] . Our experiments, however, leave the question unsolved by which mechanism 5-HT is taken up in cardiomyocytes. The data obtained only allow us to rule out a receptor-mediated endocytosis involving classical 5-HT1-5-HT4 receptors ( Figure  4), dopaminergic (Figure 5a ) or adrenergic receptors ( Figure Sb) . Recently, expression of specific 5-HT transporters (all encoded by a single gene) has been demonstrated in peripheral tissues, including lung, placenta, adrenal medulla and platelets [59] , and it is conceivable that a similar protein may be responsible for the uptake of 5-HT in cardiac myocytes, although it is so far unknown whether this type of transporter is also present in the heart.
An additional observation of potential interest is that 5-HT analogues (tryptamine, 5-methoxytryptamine) and dopamine caused an increase in glucose transport, of the same extent, and with a similar time-and concentration-dependence, as that produced by 5-HT (Figures 1 and 2 ). This indicates that the MAO-dependent mechanism operating with 5-HT may be activated by a number of other monoamines which are known to be good substrates for MAOs [43] . In line with this idea, we recently found that the stimulation of cardiomyocyte glucose transport by adrenaline or noradrenaline, which is mediated by acadrenoreceptors [49] , also comprises a slow component and is partially counteracted by MAO inhibitors (Y. Fischer and J. Thomas unpublished work).
Further investigations will be required to clarify the possible relevance of the MAO-dependent stimulation of glucose uptake found in cardiomyocytes to the serotonergic effects on glycaemia observed in vivo. For instance, it should be established whether a similar mechanism exists in skeletal muscles, which represent a major site of glucose disposal. In this context, it is noteworthy that H202 also has a stimulatory action on glucose transport in skeletal muscle [50] . Furthermore, the question arises as to whether local concentrations of monoamines could be sufficient in heart (and muscle) tissue to sustain a high rate of H202
formation. This may, in particular, hold for situations of increased monoamine release, such as sympathetic stimulation, or platelet activation. However, we are not aware of studies in which changes in 5-HT content have been quantified in heart and muscles under such conditions. It is nevertheless noteworthy that the cardiac concentrations of other monoamines such as adrenaline and noradrenaline are in the micromolar range in rats [51] . On the other hand, the generation of H202 in the respiratory chain of animal mitochondria [52] , and of heart mitochondria in particular, is well established and has been shown to be increased, depending on the energy substrates utilized [53] . Thus this additional source of H202 may lower the 5-HT or monoamine concentrations required to induce a significant enhancement of glucose uptake in heart and/or muscles.
Finally, beyond the regulation of glucose metabolism, our finding of a MAO-dependent effect of 5-HT may be of more general interest. For instance, one should consider the possibility that a similar pathway may mediate some other effects of 5-HT that were reported to necessitate relatively high concentrations of the amine, and/or that could not be ascribed to a classical 5-HT receptor type [39, 41, [54] [55] [56] [57] [58] . It is noteworthy that some of these effects impinge on the myocardial function, namely
The finding that a MAO-A-selective inhibitor (clorgyline) contractihty [54, 55] .
5-Hydroxytryptamine stimulates glucose transport in cardiomyocytes
To summarize, the stimulation of glucose transport induced by 5-HT in isolated cardiac myocytes does not appear to occur via a classical 5-HT receptor (5-HT1, 5-HT2, 5-HT3, 5-HT4), nor via a dopaminergic or aminergic receptor. Our data strongly suggest that 5-HT is metabolized by these cells through a MAOdependent pathway, and that H202 produced in the course of this 5-HT degradation eventually causes the activation of the glucose transport system. The last step of this process consists of a recruitment of glucose transporters (GLUTI, GLUT4) to the plasma membrane.
